Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2911 AL 2925

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff MG, Nam G, Kang J, Lee HJ, Lee M, Lim MH.

Chem Rev. 2019 Jan 23;119(2):1221-1322. doi: 10.1021/acs.chemrev.8b00138. Epub 2018 Aug 10.

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Cacabelos R.

Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.

Neuroprotective Role of Phytochemicals

Velmurugan BK, Rathinasamy B, Lohanathan BP, Thiyagarajan V, Weng CF.

Molecules. 2018 Sep 27;23(10):2485. doi: 10.3390/molecules23102485.

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases

Singh YP, Pandey A, Vishwakarma S, Modi G.

Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.

Golden oldies and silver brains: Deficits, preservation, learning, and rehabilitation effects of music in ageing-related neurological disorders

Särkämö T, Sihvonen AJ.

Cortex. 2018 Dec;109:104-123. doi: 10.1016/j.cortex.2018.08.034. Epub 2018 Sep 19.

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases

Teijido O, Cacabelos R.

Int J Mol Sci. 2018 Oct 16;19(10):3199. doi: 10.3390/ijms19103199.

Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease

Zhao L, Cheng X, Zhong C.

ACS Chem Neurosci. 2019 Feb 20;10(2):922-930. doi: 10.1021/acschemneuro.8b00450. Epub 2018 Dec 12.

Vitamin D basis of Alzheimer's disease: from genetics to biomarkers

Dursun E, Gezen-Ak D.

Hormones (Athens). 2019 Mar;18(1):7-15. doi: 10.1007/s42000-018-0086-5. Epub 2018 Nov 27.

Acute inability to mobilise resulting from probable donepezil-induced myoclonus

Whateley JM, Huffman AJ, Henderson EJ.

Age Ageing. 2018 Nov 1;47(6):907-908. doi: 10.1093/ageing/afy093.

Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease

Cretin B.

Expert Opin Pharmacother. 2018 Aug;19(11):1201-1209. doi: 10.1080/14656566.2018.1496237. Epub 2018 Jul 14.

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity

Parsons CG.

Neuropharmacology. 2019 Mar 15;147:4-10. doi: 10.1016/j.neuropharm.2018.08.027. Epub 2018 Aug 27.

Deep brain stimulation: potential for neuroprotection

McKinnon C, Gros P, Lee DJ, Hamani C, Lozano AM, Kalia LV, Kalia SK.

Ann Clin Transl Neurol. 2018 Nov 8;6(1):174-185. doi: 10.1002/acn3.682. eCollection 2019 Jan.

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease

Rahman SO, Singh RK, Hussain S, Akhtar M, Najmi AK.

Eur J Pharmacol. 2019 Jan 5;842:208-220. doi: 10.1016/j.ejphar.2018.10.040. Epub 2018 Oct 30.

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes

Umeno A, Biju V, Yoshida Y.

Free Radic Res. 2017 Apr;51(4):413-427. doi: 10.1080/10715762.2017.1315114. Epub 2017 Apr 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias